Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.990
-0.370 (-11.01%)
Jun 18, 2025, 4:00 PM - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $114.55 million as of June 20, 2025. Its market cap has decreased by -55.17% in one year.
Market Cap
114.55M
Enterprise Value
81.11M
1-Year Change
-55.17%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $197.44M to $114.55M, a decrease of -41.98%. That is a compound annual growth rate of -10.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 114.55M | -24.66% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |